SEATTLE--(BUSINESS WIRE)--KPI Therapeutics, a clinical-stage biotechnology company, today announced it initiated two new research programs to treat such diseases as Atopic Dermatitis, Dry Eye Syndrome ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback